LR 226 — Interim study to examine implementation of Nebraska Medical Cannabis Acts
Overview
LR 226 is a Legislative Resolution introduced on May 15, 2025, in the Nebraska Legislature. It directs an interim study by the General Affairs Committee to examine how the Nebraska Medical Cannabis Patient Protection Act and the Nebraska Medical Cannabis Regulation Act are being implemented.
Purpose
- To assess the implementation status of two key medical cannabis statutes and the role of the Nebraska Medical Cannabis Commission (NMCC).
- To ensure ongoing evaluation of regulatory processes, eligibility criteria, and access to medical cannabis in Nebraska.
Key Provisions / Study Scope
The resolution outlines four areas the interim study shall address (not limited to these):
1. NMCC registration criteria: Determine the status of criteria used to accept or deny registration applications, including the adoption, promulgation, enforcement of rules and regulations, and eligibility/registration standards.
2. Grants and establishment applications: Determine the status of grants or applications related to registered cannabis establishments under the Regulation Act.
3. NMCC status update: Receive an update on the overall status and functioning of the Nebraska Medical Cannabis Commission.
4. Stakeholder input on access: Obtain input from medical professionals, patients, and caregivers regarding the status and accessibility of medical cannabis in Nebraska.
Process and Timeline
- Committee designation: The General Affairs Committee is designated to conduct the interim study.
- Reporting: At the conclusion of the study, the committee will report its findings and recommendations to the Legislative Council or Legislature.
- Hearing notice: A hearing is scheduled for October 31, 2025.
- Legislative actions and referrals:
- May 15, 2025: Introduced and referred to the Executive Board.
- May 15, 2025: Referred to the Executive Board (originates from introduction date).
- September 3, 2025: Notice of hearing published (for the October 31, 2025 hearing).
Sponsors
- Primary sponsor: J. Cavanaugh
- Additional sponsors: Hansen, Holdcroft
Who is Affected
- Nebraska Medical Cannabis Commission and its operations
- Applicants for registration and/or cannabis establishment licenses under the Regulation Act
- Medical professionals, patients, and caregivers seeking access to medical cannabis
- General public and stakeholders involved in medical cannabis policy and regulation
Impact and Implications
- The resolution does not enact new law but initiates a formal, time-bound review of how existing medical cannabis laws are being implemented.
- Findings and recommendations could inform future legislative action, regulatory adjustments, or operations of NMCC.
- Emphasizes stakeholder engagement to gauge accessibility and effectiveness of the current framework.
Notes
- Status: Notice of hearing for October 31, 2025; ongoing referrals and committee review.
- This is a 109th Legislature, First Session resolution focused on interim oversight rather than permanent statutory changes.